A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19

por Wagener, Gebhard, Goldklang, Monica P., Gerber, Adam, Elisman, Katerina, Eiseman, Katherine A., Fonseca, Laura D., D’Armiento, Jeanine M.
Publicado 2022

Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients

por Cabrera-Garcia, David, Miltiades, Andrea, Yim, Peter, Parsons, Samantha, Elisman, Katerina, Mansouri, Mohammad Taghi, Wagener, Gebhard, Harrison, Neil L.
Publicado 2022

Mortality and renal outcomes of patients with severe COVID-19 treated in a provisional intensive care unit

por Hittesdorf, Erin, Panzer, Oliver, Wang, David, Stevens, Jacob S., Hastie, Jonathan, Jordan, Desmond A., Yoh, Nina, Eiseman, Katherine A., Elisman, Katerina, Wagener, Gebhard
Publicado 2021

Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score

por Tseng, Luke, Hittesdorf, Erin, Berman, Mitchell F., Jordan, Desmond A., Yoh, Nina, Elisman, Katerina, Eiseman, Katherine A., Miao, Yuqi, Wang, Shuang, Wagener, Gebhard
Publicado 2021